Literature DB >> 16570546

Preoperative pulmonary evaluation: identifying and reducing risks for pulmonary complications.

Gerald W Smetana1.   

Abstract

Postoperative pulmonary complications are among the most common sources of morbidity in patients undergoing major surgery. For this reason, the preoperative patient evaluation should emphasize risk factors for pulmonary complications as well as for traditional cardiac complications, as the former are comparably frequent and associated with longer hospital stays. Procedure-related risk factors are more important than patient-related risk factors for predicting pulmonary events, but clinicians should assess both types of factors. Pulmonary function testing has a limited role and should not be the basis for denying surgery if the surgical indication is compelling. Strategies to reduce the risk of postoperative pulmonary complications include optimizing management of chronic lung disease before surgery, lung expansion maneuvers, pain control, and selective placement of nasogastric tubes.

Entities:  

Mesh:

Year:  2006        PMID: 16570546     DOI: 10.3949/ccjm.73.suppl_1.s36

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  10 in total

1.  Summary of Consensus Report on Preoperative Evaluation.

Authors:  Metin Özkan; Gamze Kırkıl; Aslı Görek Dilektaşlı; Ayhan Söğüt; Bünyamin Sertoğullarından; Erdoğan Çetinkaya; Funda Coşkun; Gaye Ulubay; Hasan Yüksel; Murat Sezer; Ömer Özbudak; Sevinç Sarınç Ulaşlı; Sulhattin Arslan; Tezay Kovan
Journal:  Turk Thorac J       Date:  2015-01-01

2.  Comparison of Postoperative Pulmonary Complication Indices in Elective Abdominal Surgery Patients.

Authors:  Askin Gülsen; Oguz Kilinc; Kemal Can Tertemiz; Tuncay Ekice; Türkan Günay
Journal:  Tanaffos       Date:  2020-01

3.  A Nomogram for Prediction of Postoperative Pneumonia Risk in Elderly Hip Fracture Patients.

Authors:  Guangheng Xiang; Xiaoyu Dong; Jian Xiao; Yi-Min Weng; Tao Xu; Yongzeng Feng; Zili He; Chenrong Ke
Journal:  Risk Manag Healthc Policy       Date:  2020-09-16

4.  Incidence of Respiratory Complications Following Lumbar Spine Surgery.

Authors:  Rajan Murgai; Anthony D'Oro; Patrick Heindel; Kyle Schoell; Kaku Barkoh; Zorica Buser; Jeffrey C Wang
Journal:  Int J Spine Surg       Date:  2018-12-21

5.  Perioperative Microbiologic Monitoring of Sputum on Postoperative Day One as a Predictor of Pneumonia After Hepatectomy.

Authors:  Kazuhiko Sakamoto; Takao Tamesa; Yoshihiro Tokuhisa; Satoshi Matsukuma; Yukio Tokumitsu; Yoshinari Maeda; Shigeru Takeda; Tomio Ueno; Shigeru Yamamoto; Shigefumi Yoshino; Shoichi Hazama; Hiroaki Nagano; Masaaki Oka
Journal:  J Gastrointest Surg       Date:  2015-06-24       Impact factor: 3.452

6.  Evaluation of emphysema using three-dimensional computed tomography: association with postoperative complications in lung cancer patients.

Authors:  Kenichi Kawakami; Shingo Iwano; Naozumi Hashimoto; Yoshinori Hasegawa; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2015-02       Impact factor: 1.131

Review 7.  Perioperative lung protection.

Authors:  Katherine Marseu; Peter Slinger
Journal:  Korean J Anesthesiol       Date:  2017-05-26

Review 8.  Pre-operative optimisation of lung function.

Authors:  Naheed Azhar
Journal:  Indian J Anaesth       Date:  2015-09

Review 9.  Anaesthesia for patient with chronic obstructive pulmonary disease.

Authors:  Devika Rani Duggappa; G Venkateswara Rao; Sudheesh Kannan
Journal:  Indian J Anaesth       Date:  2015-09

10.  Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study.

Authors:  Christopher Uhlig; Ary Serpa Neto; Meta van der Woude; Thomas Kiss; Jakob Wittenstein; Benjamin Shelley; Helen Scholes; Michael Hiesmayr; Marcos Francisco Vidal Melo; Daniele Sances; Nesil Coskunfirat; Paolo Pelosi; Marcus Schultz; Marcelo Gama de Abreu
Journal:  BMC Anesthesiol       Date:  2020-07-22       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.